StockDuty ← Dashboard Aug 20, 2026 08:10 AM ET
SignalCorporate

NOVOZYMES Q2 REVENUE UP 9.8% Y/Y; RAISES FY26 ORGANIC SALES GROWTH OUTLOOK, INAUGURAL €1B SHARE BUYBACK PLAN - SEEKINGALPHA

Q2 revenue up 9.8% Y/Y, raised FY26 outlook, and inaugural €1B buyback.

Q2 revenue up 9.8% Y/Y, raised FY26 outlook, and inaugural €1B buyback.
Sources